The role of rs1799889 genetic variation in type 2 diabetes and diabetic nephropathy risk
View/ Open
Access
info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc/3.0/us/Date
2020Metadata
Show full item recordCitation
Bayramoğlu, A., Bayramoğlu, G., & Güler, H. İ. (2020). The Role of rs1799889 Genetic Variation in Type 2 Diabetes and Diabetic Nephropathy Risk. Erciyes Medical Journal/Erciyes Tip Dergisi, 42(4), 441-446.Abstract
AI-1 gene 4G/5G and to investigate the role of this polymorphism in T2 DM and DN development.
Materials and Methods: The genomic DNA of the 261 individuals was included in this study. The polymerase chain reaction (PCR) method with 4G and 5G allele-particular primers was used to identify the polymorphism of PAI-1 4G/5G. The
PCR products were evaluated using a CCD camera after 2% agarose gel electrophoresis.
Results: Although the frequencies of the gene genotypes differed statistically significant between 80 patients and 51 patients
with and without DN, respectively, and the control group, no statistically significant difference was detected between those
with and without DN. The 5G/5G genotype was found to be significantly higher in the patient group.
Conclusion: The findings suggest that there is a significant correlation between variants of the PAI-1 gene and the risk for
T2 DM formation.
Source
Erciyes Medical Journal/ Erciyes Tip DergisiVolume
42Issue
4Collections
The following license files are associated with this item: